Knaus Tabbert AG | Finanzwire

PRESS RELEASE

published on 02/12/2024 at 15:41, 9 months 10 days ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research has reiterated a Buy rating on Knaus Tabbert AG with a price target of €86, citing good business momentum and potential for revenue and margin expansion. Recent industry data supports optimism about the RV demand normalization and untapped potential for Knaus

First Berlin Equity Research BUY Rating Knaus Tabbert AG Revenue Expansion RV Demand
PRESS RELEASE

published on 02/05/2024 at 08:11, 9 months 18 days ago

KNAUS remains the strongest motorhome brand in terms of new registrations in Germany in 2023
Knaus Tabbert AG establishes KNAUS as the leading motorhome brand in Germany with 8.6% market share, marking a 70% increase in new registrations in 2023. Weinsberg also secures a top position with a 5.7% market share

Germany Knaus Tabbert AG KNAUS Motorhome Brand New Registrations
PRESS RELEASE

published on 11/09/2023 at 10:41, 1 year ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
PRESS RELEASE

published on 11/08/2023 at 07:00, 1 year ago

Knaus Tabbert remains on the fast track. Strong revenue and earnings growth in the third quarter of 2023.
PRESS RELEASE

published on 09/20/2023 at 15:36, 1 year 2 months ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
PRESS RELEASE

published on 09/20/2023 at 06:53, 1 year 2 months ago

EQS-Adhoc: Knaus Tabbert AG: KNAUS TABBERT AG provides a more detailed revenue forecast and increases the forecast for the adjusted EBITDA margin for the financial year 2023
PRESS RELEASE

published on 09/06/2023 at 12:31, 1 year 2 months ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
PRESS RELEASE

published on 08/14/2023 at 11:31, 1 year 3 months ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
PRESS RELEASE

published on 08/10/2023 at 07:00, 1 year 3 months ago

Knaus Tabbert AG: Knaus Tabbert achieves record result in second quarter of 2023 and remains on growth track
PRESS RELEASE

published on 07/26/2023 at 09:21, 1 year 3 months ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen

Published on 11/22/2024 at 23:55, 11 hours 19 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 44 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 12 hours 9 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 12 hours 9 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 44 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 16 hours 59 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 17 hours 14 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 17 hours 20 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 18 hours 18 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 19 hours 14 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 20 hours 39 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 17 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 17 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News